Idiopathic pulmonary fibrosis primary prevention: Difference between revisions
(Created page with "__NOTOC__ Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. {{Idiopathic pulmonary fibrosis}} ==Refer...") |
No edit summary |
||
(6 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Idiopathic pulmonary fibrosis}} | |||
{{CMG}}; {{AE}} {{AEL}} | |||
==Overview== | |||
The primary prevention of idiopathic pulmonary fibrosis or usual interstitial pneumonia includes [[smoking cessation]] and [[vaccination]] against [[influenza]]. | |||
==Primary Prevention== | |||
===General Considerations=== | |||
*There are several ways to prevent pulmonary fibrosis or usual interstitial pneumonia. Appropriately treating underlying illnesses (such as [[AIDS]]) can decrease an individual's risk of [[pneumonia]]. | |||
*[[Smoking cessation]] is important not only because it helps to limit lung damage, but also because cigarette smoke interferes with many of the body's natural defenses against [[pneumonia]]. | |||
*There are several ways to prevent [[pneumonia]] in newborn [[infant]]s. Testing pregnant women for [[Group B Streptococcus|Group B ''Streptococcus'']] and ''[[chlamydia trachomatis]]'', and then giving [[antibiotic]] treatment if needed, reduces [[pneumonia]] in infants. Suctioning the mouth and throat of infants with [[meconium]]-stained [[amniotic fluid]] decreases the rate of [[aspiration pneumonia]]. | |||
*[[Vaccination]] is important for preventing [[pneumonia]] in both children and adults. Vaccinations against ''[[haemophilus influenzae]]'' and ''[[streptococcus pneumoniae]]'' in the first year of life have greatly reduced their role in [[pneumonia]] in children. | |||
*Vaccinating children against ''[[streptococcus pneumoniae]]'' has also led to a decreased incidence of these infections in adults because many adults acquire infections from children. A [[Pneumococcal polysaccharide vaccine|vaccine against ''streptococcus pneumoniae'']] is also available for adults.<ref name="butler">Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations.'' JAMA'' 1993;270:1826–1831. PMID 8411526</ref>. | |||
*[[Influenza]] vaccines should be given yearly to the same individuals who receive [[vaccination]] against ''[[streptococcus pneumoniae]]''. In addition, health care workers, nursing home residents, and pregnant women should receive the [[vaccine]].<ref name="CDC">Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)''. MMWR'' 1999;48(RR-4):1–28. PMID 10366138.</ref> | |||
*When an [[influenza]] outbreak is occurring, medications such as [[amantadine]], [[rimantadine]], [[zanamivir]], and [[oseltamivir]] can help prevent [[influenza]].<ref name="jefferson">Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults.''Cochrane Database Syst Rev.'' 2004;(3):CD001169. PMID 15266442</ref><sup>,</sup><ref name="hayden">Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.'' N Engl J Med'' 1999;341:1336–1343PMID 10536125</ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
Latest revision as of 14:12, 3 April 2018
Idiopathic pulmonary fibrosis Microchapters |
Differentiating Idiopathic pulmonary fibrosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Idiopathic pulmonary fibrosis primary prevention On the Web |
American Roentgen Ray Society Images of Idiopathic pulmonary fibrosis primary prevention |
Idiopathic pulmonary fibrosis primary prevention in the news |
Directions to Hospitals Treating Idiopathic pulmonary fibrosis |
Risk calculators and risk factors for Idiopathic pulmonary fibrosis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
The primary prevention of idiopathic pulmonary fibrosis or usual interstitial pneumonia includes smoking cessation and vaccination against influenza.
Primary Prevention
General Considerations
- There are several ways to prevent pulmonary fibrosis or usual interstitial pneumonia. Appropriately treating underlying illnesses (such as AIDS) can decrease an individual's risk of pneumonia.
- Smoking cessation is important not only because it helps to limit lung damage, but also because cigarette smoke interferes with many of the body's natural defenses against pneumonia.
- There are several ways to prevent pneumonia in newborn infants. Testing pregnant women for Group B Streptococcus and chlamydia trachomatis, and then giving antibiotic treatment if needed, reduces pneumonia in infants. Suctioning the mouth and throat of infants with meconium-stained amniotic fluid decreases the rate of aspiration pneumonia.
- Vaccination is important for preventing pneumonia in both children and adults. Vaccinations against haemophilus influenzae and streptococcus pneumoniae in the first year of life have greatly reduced their role in pneumonia in children.
- Vaccinating children against streptococcus pneumoniae has also led to a decreased incidence of these infections in adults because many adults acquire infections from children. A vaccine against streptococcus pneumoniae is also available for adults.[1].
- Influenza vaccines should be given yearly to the same individuals who receive vaccination against streptococcus pneumoniae. In addition, health care workers, nursing home residents, and pregnant women should receive the vaccine.[2]
- When an influenza outbreak is occurring, medications such as amantadine, rimantadine, zanamivir, and oseltamivir can help prevent influenza.[3],[4]
References
- ↑ Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826–1831. PMID 8411526
- ↑ Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999;48(RR-4):1–28. PMID 10366138.
- ↑ Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults.Cochrane Database Syst Rev. 2004;(3):CD001169. PMID 15266442
- ↑ Hayden FG, Atmar RL, Schilling M, Johnson C, Poretz D, Paar D, Huson L, Ward P, Mills RG. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336–1343PMID 10536125